Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy

Abstract Background 211At is a high-energy α-ray emitter with a relatively short half-life and a high cytotoxicity for cancer cells. Its dispersion can be imaged using clinical scanners, and it can be produced in cyclotrons without the use of nuclear fuel material. This study investigated the biodis...

Full description

Bibliographic Details
Main Authors: Hiroki Kato, Xuhao Huang, Yuichiro Kadonaga, Daisuke Katayama, Kazuhiro Ooe, Atsushi Shimoyama, Kazuya Kabayama, Atsushi Toyoshima, Atsushi Shinohara, Jun Hatazawa, Koichi Fukase
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-021-00963-9
id doaj-6c774306ce0d4817af2fa2f2c28fe432
record_format Article
spelling doaj-6c774306ce0d4817af2fa2f2c28fe4322021-08-01T11:32:26ZengBMCJournal of Nanobiotechnology1477-31552021-07-0119111210.1186/s12951-021-00963-9Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapyHiroki Kato0Xuhao Huang1Yuichiro Kadonaga2Daisuke Katayama3Kazuhiro Ooe4Atsushi Shimoyama5Kazuya Kabayama6Atsushi Toyoshima7Atsushi Shinohara8Jun Hatazawa9Koichi Fukase10Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of MedicineDepartment of Chemistry, Graduate School of Science, Osaka UniversityDivision of Science, Institute for Radiation Sciences, Osaka UniversityDepartment of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of MedicineDepartment of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of MedicineDepartment of Chemistry, Graduate School of Science, Osaka UniversityDepartment of Chemistry, Graduate School of Science, Osaka UniversityDivision of Science, Institute for Radiation Sciences, Osaka UniversityDepartment of Chemistry, Graduate School of Science, Osaka UniversityResearch Center for Nuclear Physics, Osaka UniversityDepartment of Chemistry, Graduate School of Science, Osaka UniversityAbstract Background 211At is a high-energy α-ray emitter with a relatively short half-life and a high cytotoxicity for cancer cells. Its dispersion can be imaged using clinical scanners, and it can be produced in cyclotrons without the use of nuclear fuel material. This study investigated the biodistribution and the antitumor effect of 211At-labeled gold nanoparticles (211At-AuNP) administered intratumorally. Results AuNP with a diameter of 5, 13, 30, or 120 nm that had been modified with poly (ethylene glycol) methyl ether (mPEG) thiol and labeled with 211At (211At-AuNP-S-mPEG) were incubated with tumor cells, or intratumorally administered to C6 glioma or PANC-1 pancreatic cancers subcutaneously transplanted into rodent models. Systemic and intratumoral distributions of the particles in the rodents were then evaluated using scintigraphy and autoradiography, and the changes in tumor volumes were followed for about 40 days. 211At-AuNP-S-mPEG was cytotoxic when it was internalized by the tumor cells. After intratumoral administration, 211At-AuNP-S-mPEG became localized in the tumor and did not spread to systemic organs during a time period equivalent to 6 half-lives of 211At. Tumor growth was strongly suppressed for both C6 and PANC-1 by 211At-AuNP-S-mPEG. In the C6 glioma model, the strongest antitumor effect was observed in the group treated with 211At-AuNP-S-mPEG with a diameter of 5 nm. Conclusions The intratumoral single administration of a simple nanoparticle, 211At-AuNP-S-mPEG, was shown to suppress the growth of tumor tissue strongly in a particle size-dependent manner without radiation exposure to other organs caused by systemic spread of the radionuclide. Graphic Abstracthttps://doi.org/10.1186/s12951-021-00963-9Astatine-211Alpha emittersGold nanoparticlesRadiolabelingCancer therapy
collection DOAJ
language English
format Article
sources DOAJ
author Hiroki Kato
Xuhao Huang
Yuichiro Kadonaga
Daisuke Katayama
Kazuhiro Ooe
Atsushi Shimoyama
Kazuya Kabayama
Atsushi Toyoshima
Atsushi Shinohara
Jun Hatazawa
Koichi Fukase
spellingShingle Hiroki Kato
Xuhao Huang
Yuichiro Kadonaga
Daisuke Katayama
Kazuhiro Ooe
Atsushi Shimoyama
Kazuya Kabayama
Atsushi Toyoshima
Atsushi Shinohara
Jun Hatazawa
Koichi Fukase
Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
Journal of Nanobiotechnology
Astatine-211
Alpha emitters
Gold nanoparticles
Radiolabeling
Cancer therapy
author_facet Hiroki Kato
Xuhao Huang
Yuichiro Kadonaga
Daisuke Katayama
Kazuhiro Ooe
Atsushi Shimoyama
Kazuya Kabayama
Atsushi Toyoshima
Atsushi Shinohara
Jun Hatazawa
Koichi Fukase
author_sort Hiroki Kato
title Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
title_short Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
title_full Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
title_fullStr Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
title_full_unstemmed Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
title_sort intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
publisher BMC
series Journal of Nanobiotechnology
issn 1477-3155
publishDate 2021-07-01
description Abstract Background 211At is a high-energy α-ray emitter with a relatively short half-life and a high cytotoxicity for cancer cells. Its dispersion can be imaged using clinical scanners, and it can be produced in cyclotrons without the use of nuclear fuel material. This study investigated the biodistribution and the antitumor effect of 211At-labeled gold nanoparticles (211At-AuNP) administered intratumorally. Results AuNP with a diameter of 5, 13, 30, or 120 nm that had been modified with poly (ethylene glycol) methyl ether (mPEG) thiol and labeled with 211At (211At-AuNP-S-mPEG) were incubated with tumor cells, or intratumorally administered to C6 glioma or PANC-1 pancreatic cancers subcutaneously transplanted into rodent models. Systemic and intratumoral distributions of the particles in the rodents were then evaluated using scintigraphy and autoradiography, and the changes in tumor volumes were followed for about 40 days. 211At-AuNP-S-mPEG was cytotoxic when it was internalized by the tumor cells. After intratumoral administration, 211At-AuNP-S-mPEG became localized in the tumor and did not spread to systemic organs during a time period equivalent to 6 half-lives of 211At. Tumor growth was strongly suppressed for both C6 and PANC-1 by 211At-AuNP-S-mPEG. In the C6 glioma model, the strongest antitumor effect was observed in the group treated with 211At-AuNP-S-mPEG with a diameter of 5 nm. Conclusions The intratumoral single administration of a simple nanoparticle, 211At-AuNP-S-mPEG, was shown to suppress the growth of tumor tissue strongly in a particle size-dependent manner without radiation exposure to other organs caused by systemic spread of the radionuclide. Graphic Abstract
topic Astatine-211
Alpha emitters
Gold nanoparticles
Radiolabeling
Cancer therapy
url https://doi.org/10.1186/s12951-021-00963-9
work_keys_str_mv AT hirokikato intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
AT xuhaohuang intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
AT yuichirokadonaga intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
AT daisukekatayama intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
AT kazuhiroooe intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
AT atsushishimoyama intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
AT kazuyakabayama intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
AT atsushitoyoshima intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
AT atsushishinohara intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
AT junhatazawa intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
AT koichifukase intratumoraladministrationofastatine211labeledgoldnanoparticleforalphatherapy
_version_ 1721245779869302784